Amgen Inc
Close on Nov 2, 2026Market cap $251.64BP/E 28.9Yield 2.08%
Amgen UPLIZNA (inebilizumab-cdon by Quarter
UPLIZNA (inebilizumab-cdon — NMOSD & IgG4-Related Disease) — U.S. product sales ($M) ($M)
Amgen UPLIZNA (inebilizumab-cdon: $317M in Q2 2026, up 140.2% from a year earlier. That is the highest of the 11 quarters on record here.
Where the Q2 2026 figure comes from
Source: Form 10-Q (filed 2026-08-05) ↗
Reported in Form 10-Q / 10-K Segment & Revenue Disaggregation Note & Form 8-K Product Sales Detail.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | UPLIZNA (inebilizumab-cdon — NMOSD & IgG4-Related Disease) — U.S. product sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 317 | +140.2% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 246 | +200.0% | Form 10-Q (filed 2026-05-01) ↗ |
| Q4 2025 | Dec 31, 2025 | 168 | +80.6% | Form 8-K (amgn-20251231earningsrelea.htm, filed 2026-02-03) ↗ |
| Q3 2025 | Sep 30, 2025 | 146 | +97.3% | Form 8-K (amgn-20250930earningsrelea.htm, filed 2025-11-04) ↗ |
| Q2 2025 | Jun 30, 2025 | 132 | +71.4% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 82 | +17.1% | Form 10-Q (filed 2026-05-01) ↗ |
| Q4 2024 | Dec 31, 2024 | 93 | +55.0% | Form 8-K (amgn-20241231earningsrelea.htm, filed 2025-02-04) ↗ |
| Q3 2024 | Sep 30, 2024 | 74 | – | Form 8-K (amgn-20240930earningsrelea.htm, filed 2024-10-30) ↗ |
| Q2 2024 | Jun 30, 2024 | 77 | – | Form 8-K (amgn-20240630earningsrelea.htm, filed 2024-08-06) ↗ |
| Q1 2024 | Mar 31, 2024 | 70 | – | Form 8-K (amgn-20240331earningsrelea.htm, filed 2024-05-02) ↗ |
| Q4 2023 | Dec 31, 2023 | 60 | – | Form 8-K (amgn-20231231earningsrelea.htm, filed 2024-02-06) ↗ |
Cite this data
StockData. (2026). Amgen UPLIZNA (inebilizumab-cdon ($M), quarterly Q4 2023–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/prod-uplizna-us
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.